PacBio Corp - PACB Real Price to Acquire Entire Company

PacBio Corp (PACB) - corporate logo

The price evolution of Pacific Biosciences (PACB) allows for an assessment of business resilience amid rapid cash burn and the struggle for market share, with the current indicator standing at 1230.76. The developer relies on the implementation of ultra-precise genome sequencing methods within the agricultural sector and medicine. Stringent patent requirements and software complexity create a robust barrier to entry for new industry players.

PACB PacBio Corp: Enterprise Value in the range 11/23/2025 - 10/28/2026

Pacific Biosciences (PACB) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price Pacific Biosciences of California, Inc.|PACB - Analyst Consensus Forecast
- market capitalization data:
Market Valuation PacBio|PACB - Enterprise Value
- book capitalization data:
Net Assets per Single Share PacBio|PACB - Book Capitalization|Capitalization to Book Value Ratio pacb.com|PACB - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio Pacific Biosciences|PACB - Long-Term Debt to Capital|Short-Term Debt to Capital pacb.com|PACB - Company Debts|Debts to Book Capitalization Ratio PacBio|PACB - Company Long-Term Debts|Company Short-Term Debts PacBio
Basic company analysis:PACB (Pacific Biosciences of California, Inc.)
Original product of Pacific Biosciences

Enterprise value combines market capitalization with net debt, reflecting the total cost of acquiring a business inclusive of all financial obligations. For Pacific Biosciences (PACB), whose value is based on costly patents and R&D, the net market value of the business demonstrates how the market prices in technological superiority in DNA sequencing relative to the company's debt load.

Who Pacific Biosciences competes with

Enterprise Value Tempus AI TEM|QGEN: Enterprise Value|IONS - Real Price to Acquire Entire Company|Repligen Corporation (RGEN) - Enterprise Value|aviditybiosciences.com (RNA) - Total Company Value|Enterprise Value CRISPR Therapeutics (CRSP)|Business Value WGS|Total Company Value Ultragenyx Pharma RARE|Business Value Beam Tx (BEAM)|Enterprise Value SRPT (Sarepta Therapeutics, Inc.)|twistbioscience.com - Enterprise Value|Total Company Value 10x Genomics|NTLA - Full Business Value|STOK: Enterprise Value|BioLife (BLFS) - Enterprise Value|Enterprise Value WVE|Real Price to Acquire Entire Company mazetx.com|SION (Sionna Therapeutics) - Enterprise Value|Company Buyout Price Prime Medicine Inc (PRME)|Taysha (TSHA) - Enterprise Value|Full Business Value uniQure Pharma QURE|Enterprise Value MGTX (MeiraGTx Holdings plc)|RGNX - Company Buyout Price|SLDB (Solid Biosciences) - Enterprise Value|Real Price to Acquire Entire Company Ocugen Inc|BNTC - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Design Corp|Enterprise Value Rocket Pharmaceuticals (RCKT)|Total Company Value 4dmoleculartherapeutics.com (FDMT)|Enterprise Value LXEO|Korro Bio Inc. - Company Buyout Price|EDIT (Editas) - Total Company Value|SLN: Total Enterprise Value|proqr.com - Total Company Value|Codexis (CDXS) - Company Buyout Price|Enterprise Value SGMO|Real Price to Acquire Entire Company Nautilus Biotechnology Inc|MGX (Metagenomi, Inc) - Enterprise Value|Company Buyout Price precisionbiosciences.com (DTIL)|GBIO: Enterprise Value|boundlessbio.com - Total Enterprise Value|Exicure Corp (XCUR) - Total Company Value|IMNN - Business Value|PHIO (phiopharma.com) - Enterprise Value|Mustang Bio (MBIO) - Real Price to Acquire Entire Company|Enterprise Value RNAZ (TransCode Therapeutics Inc.)|Total Enterprise Value BNGO|APDN (Applied DNA Sciences, Inc.) - Total Company Value|Company Buyout Price BLUE (bluebird bio Inc.)|ImmunoPrecise Antibodies Ltd. (IPA) - Total Company Value|Full Business Value Omega Therapeutics Corp OMGA|Singular Genomics Systems - Enterprise Value|RGLS - Enterprise Value|SYRS (Syros Pharmaceuticals, Inc.) - Enterprise Value|Telesis Bio Inc. (TBIO) - Real Price to Acquire Entire Company|Enterprise Value TRACON|Total Company Value Unity Biotechnology, Inc